The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm.
Viswanathan Mohan, Mark E Cooper, David R Matthews, Kamlesh Khunti
Diabetes Therapy | Published : 2019
There is currently a worldwide epidemic of type 2 diabetes (T2D) that is predicted to increase substantially in the next few years. With 80% of the global T2D population living in low to middle-income countries, there are issues with cost and of access to appropriate medicines. The objective of this symposium was to provide an overview of the efficacy and safety of glucose-lowering drugs, focussing in particular on sulfonylureas (SUs) in patients with T2D using data taken from both randomised controlled trials (RCTs) and real-world studies, the application of strategies to ensure optimal patient adherence and clinical outcomes, and the optimal use of SUs in terms of dose adjustment and agent..View full abstract